Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington’s disease

Mitochondrial abnormalities and redox imbalance are major pathogenic factors in progression of Huntington’s disease (HD), manifested clinically by affective, motor, cognitive, and psychiatric incompetence. Antioxidants behold much promise in mitigation of several pathological facets in HD. Ellagic a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Naunyn-Schmiedeberg's archives of pharmacology 2021-09, Vol.394 (9), p.1917-1928
Hauptverfasser:	Sharma, Priya, Kumar, Manish, Bansal, Nitin
Format:	Artikel
Sprache:	eng
Schlagworte:	3-Nitropropionic acid Acids Animals Antioxidants Biomedical and Life Sciences Biomedicine Catalase Catalase - metabolism Cognition Disorders - prevention & control Cognitive ability Dehydrogenases Disease Models, Animal Dose-Response Relationship, Drug Ellagic acid Ellagic Acid - administration & dosage Ellagic Acid - pharmacology Functional foods & nutraceuticals Glutathione Glutathione - metabolism Huntington Disease - prevention & control Huntington's disease Huntingtons disease Male Maze Learning - drug effects Mitochondria Mitochondria - drug effects Neuroprotection Neuroprotective Agents - administration & dosage Neuroprotective Agents - pharmacology Neurosciences Nitro Compounds Original Article Oxidative stress Pattern recognition Pharmacology/Toxicology Propionates Rats Rats, Wistar Succinate dehydrogenase Thiobarbituric acid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!